CDC Opens State Ordering for COVID-19 Vaccines

The CDC has started allowing states to order COVID-19 vaccines. The move comes after a delay that the health department had attributed to unfinished procurement decisions.
The Centers for Disease Control and Prevention (CDC) has begun accepting orders from states for COVID-19 vaccines. This development follows a period of delay, during which the health department cited unfinished procurement decisions as the reason. The CDC's decision to open ordering for the vaccines is a significant step in the ongoing effort to combat the COVID-19 pandemic. States can now place their orders, which will help to ensure a steady supply of vaccines for their residents. The exact timeline for vaccine distribution is still being determined, but the CDC's action is seen as a positive step forward. The health department had previously stated that the delay was due to procurement decisions that had not yet been finalized, but it appears that those issues have now been resolved. The CDC will continue to work with states to ensure a smooth rollout of the vaccines.
Go Deeper
What caused the delay in state ordering for COVID-19 vaccines?
The health department attributed the delay to unfinished procurement decisions, which have now been resolved.
How will the vaccines be distributed to states?
The CDC will work with states to ensure a smooth rollout of the vaccines, although the exact timeline is still being determined.
What does this development mean for the COVID-19 pandemic?
The CDC's decision to open ordering for vaccines is a significant step in the ongoing effort to combat the pandemic, and will help to ensure a steady supply of vaccines for residents.
Can states place orders for the vaccines now?
Yes, states can now place their orders for COVID-19 vaccines through the CDC.
What is the next step in the vaccine distribution process?
The CDC will continue to work with states to ensure a smooth rollout of the vaccines, and will provide further guidance as needed.
More health
An Experimental Alzheimer's Drug Showed Stronger Benefit at Two Years, but the Numbers Call for Caution
An experimental drug called diranersen showed hopeful two-year results in a study of people with early Alzheimer's disease, including about a 54 perce
Nov 21health50+Flu Is Spreading Early This Year, and Older Adults Face the Highest Risk
Flu is spreading unusually early this year, and adults 65 and older face the highest risk of being hospitalized. Doctors recommend a stronger flu shot
Nov 20health50+Medicare's Open Enrollment Ends December 7, and Some Costs Will Rise in 2027
Medicare's open enrollment ends December 7, and several costs, including the Part D out-of-pocket cap, are rising in 2027. There is still time to swit
Nov 20